ARDS

home  ›  advanced  ›  ards

ARDS

immediate assessment

Think ARDS whenever a patient with a plausible trigger develops new or worsening bilateral hypoxemia within about a week of the insult.

  • common triggers pneumonia, sepsis, aspiration, pancreatitis, major trauma, transfusion, inhalation injury.
  • first actions increase FiO2 to hold saturation; chest x-ray; arterial blood gas; treat the trigger in parallel. Once intubated, start lung-protective settings immediately; do not wait for a full workup.
  • non-invasive support HFNC or NIV trial in mild hypoxemia with close monitoring (HFNC / NIV); do not delay intubation if oxygenation is not maintained or work of breathing escalates.
early recognition, do not wait for the label
  • bilateral opacities not fully explained by fluid overload or cardiac failure, a plausible cause, onset within a week; the 2023/2024 update extends recognition to non-intubated patients on HFNC (define & classify below).

define & classify

Berlin Definition, 2012, still the working framework, all four criteria required (1):

  • timing new or worsening respiratory symptoms within 1 week of a known clinical insult.
  • imaging bilateral opacities on chest x-ray or CT, not fully explained by effusion, lobar/lung collapse, or nodules.
  • origin of edema respiratory failure not fully explained by cardiac failure or fluid overload; objective assessment (echo) if no clear risk factor.
  • oxygenation P/F ratio measured on PEEP or CPAP ≥ 5 cmH2O.
200-300P/F, mildlung-protective ventilation, treat the trigger, reassess frequently. A large fraction resolve without progressing.
100-200P/F, moderatehigher-PEEP strategy, consider early prone positioning if trending toward severe.
< 100P/F, severeprone positioning, consider neuromuscular blockade, discuss ECMO referral early. This is an ICU patient.

the 2023/2024 global definition keeps these bands, adds SpO2/FiO2 < 315 and high-flow nasal oxygen ≥ 30 L/min as alternative criteria, and allows lung ultrasound for imaging (2): this extends recognition to non-intubated and resource-limited settings. It does not change how you ventilate an intubated patient.

initial management

lung-protective ventilation, start immediately
  • tidal volume 6 mL/kg predicted body weight, calculated by height and sex, not actual weight (3). Full setup detail on mechanical ventilation.
  • plateau pressure < 30 cmH2O, driving pressure < 15 cmH2O where achievable (4).
  • oxygenation target SpO2 88-95% or PaO2 55-80 mmHg, do not chase normal saturations.
  • permissive hypercapnia to protect these limits: pH down to about 7.20-7.25 without correcting it; avoid in raised intracranial pressure or severe pulmonary hypertension.
fluid strategy
  • once shock is resolved, conservative fluid strategy, net even to negative balance: more ventilator-free days without worse kidney or shock outcomes (FACTT trial).
  • conditional on hemodynamic stability, do not under-resuscitate active shock to chase a negative balance. See shock and IV fluids.
PEEP
  • moderate to severe ARDS (P/F < 200): higher-PEEP strategy beats low PEEP (5); use the high-PEEP/FiO2 ladder on mechanical ventilation.
  • titrate PEEP against oxygenation and plateau/driving pressure together. More PEEP that pushes plateau pressure over target is not a win.

reassess

  • arterial blood gas 30-60 min after intubation and after any major setting change.
  • trend the P/F ratio, not a single value, this drives escalation decisions.
  • daily assessment for sedation reduction and spontaneous breathing trial readiness once the P/F ratio and driving pressure are improving.
  • reassess the trigger: worsening ARDS despite good vent management usually means the underlying process (infection, pancreatitis, aspiration) is not yet controlled.

advanced management

prone positioning
  • criteria (6): P/F ratio < 150 on FiO2 > 0.6 and PEEP ≥ 5, within about 36 hours of ARDS onset.
  • prone ≥ 16 hours/day: roughly halved mortality in the original trial; needs a trained team and a protocol, not a solo maneuver.
neuromuscular blockade, selective not routine
  • ACURASYS (2010) showed a mortality benefit from early cisatracurium in severe ARDS with deep sedation (7).
  • ROSE (2019), larger, same drug and dose, light-sedation comparator: no mortality benefit, more ICU-acquired weakness and serious cardiovascular events with early blockade (8).
  • practical: no routine paralysis; reserve for persistent severe dyssynchrony or refractory hypoxemia despite optimized sedation, and keep it short.
recruitment maneuvers, use caution
  • brief recruitment maneuvers can transiently improve oxygenation, but the PHARLAP “staircase” high-pressure strategy increased arrhythmias and hemodynamic instability without mortality benefit (9): not routine; if attempted, keep it brief and be ready for hypotension or desaturation.
corticosteroids, evidence is evolving
  • DEXA-ARDS (2020) showed a mortality benefit from dexamethasone 20 mg IV daily × 5 days, then 10 mg IV daily × 5 days in moderate to severe ARDS (10).
  • SCCM 2024 focused update: conditional recommendation for corticosteroids in critically ill ARDS (11), no mandated agent, dose, or duration; starting late (> 14 days after onset) may harm. Agent, dose and timing are an ICU discussion, not an automatic order.

troubleshooting

  • P/F ratio < 150 despite FiO2 1.0 and an optimized high-PEEP strategy prone position if not already done.
  • already proned, still severely hypoxemic look for a reversible complication (pneumothorax, mucus plug, worsening trigger) before calling it refractory; see ventilator troubleshooting.
  • rising plateau or driving pressure on a fixed tidal volume compliance is worsening: reassess fluid balance and the trigger, not just the vent.
  • fighting the vent despite optimized sedation consider short-course neuromuscular blockade, see advanced management above.
  • refractory hypoxemia or hypercapnia despite prone positioning and optimized settings ECMO referral criteria below.

escalation / ICU

call ICU urgently for
  • any moderate to severe ARDS, P/F < 150, this is an ICU patient by definition.
  • refractory hypoxemia despite lung-protective ventilation, high PEEP, and proning.
  • ECMO referral criteria (12), any one of: P/F < 50 for > 3 hr, P/F < 80 for > 6 hr, or pH ≤ 7.25 with PaCO2 ≥ 60 mmHg for > 6 hr despite optimized settings.
  • hemodynamic instability requiring escalating vasopressor support alongside high ventilatory pressures.
  • new pneumothorax or barotrauma on high-pressure ventilation.

pearls & pitfalls

  • neuromuscular blockade and corticosteroids remain genuinely debated: know the trial names; neither is a reflex order.
  • proning is one of the few ARDS interventions with a large mortality benefit: do not skip it in eligible patients because it is logistically hard.
  • P/F falling despite a “correct” vent = look at the patient again, not just the ventilator.

sources

go deeper the full MOC+ Acute Medicine set covers the on-call essentials.
More clinical resources in the MOC+ Library →

Last updated · September 2026